» Articles » PMID: 3364953

Pharmacokinetics of Carumonam After Single and Multiple 1- and 2-g Dosage Regimens

Overview
Specialty Pharmacology
Date 1988 Mar 1
PMID 3364953
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of carumonam after single and multiple intravenous administration of 1- and 2-g dosage regimens were studied in 12 young male volunteers. Plasma and urine samples were collected in serial order for 24 h and assayed by high-pressure liquid chromatography. The mean elimination half-life of carumonam was not significantly affected by either dosage regimen or single dose versus steady state, ranging from 1.3 to 1.5 h. Mean concentrations at the end of the interval were not influenced by a multiple-dose administration. The normalized volume of distribution was independent of the dose, with values ranging from 0.16 to 0.19 liters/kg. After multiple administration, carumonam was cleared from the body more rapidly: from 96.2 to 121.7 ml/min after 1 g every 8 h, and from 102.1 to 122.3 ml/min after 2 g every 8 h (P less than 0.05). After 24 h, 75.0 to 80.7% of the dose was excreted unchanged in the urine. The protein binding of carumonam to human plasma remained stable at 28%. Carumonam was well tolerated by the volunteers.

Citing Articles

Pharmacokinetics of carumonam (AMA-1080) in patients with impaired renal function and in those undergoing hemodialysis.

Konishi K, Suzuki H, Saruta T, Deguchi N, Fugono T Antimicrob Agents Chemother. 1991; 35(6):1048-52.

PMID: 1929242 PMC: 284284. DOI: 10.1128/AAC.35.6.1048.

References
1.
McNulty C, Garden G, Ashby J, Wise R . Pharmacokinetics and tissue penetration of carumonam, a new synthetic monobactam. Antimicrob Agents Chemother. 1985; 28(3):425-7. PMC: 180266. DOI: 10.1128/AAC.28.3.425. View

2.
Imada A, Kondo M, OKONOGI K, Yukishige K, Kuno M . In vitro and in vivo antibacterial activities of carumonam (AMA-1080), a new N-sulfonated monocyclic beta-lactam antibiotic. Antimicrob Agents Chemother. 1985; 27(5):821-7. PMC: 180159. DOI: 10.1128/AAC.27.5.821. View

3.
Neu H . Antibiotics in the second half of the 1980s. Areas of future development and the effect of new agents on aminoglycoside use. Am J Med. 1986; 80(6B):195-203. DOI: 10.1016/0002-9343(86)90501-2. View

4.
Horber F, Egger H, Weidekamm E, Dubach U, Frey F, Probst P . Pharmacokinetics of carumonam in patients with renal insufficiency. Antimicrob Agents Chemother. 1986; 29(1):116-21. PMC: 180375. DOI: 10.1128/AAC.29.1.116. View

5.
Neu H, Chin N, Labthavikul P . The in-vitro activity and beta-lactamase stability of carumonam. J Antimicrob Chemother. 1986; 18(1):35-44. DOI: 10.1093/jac/18.1.35. View